Kacper Lechowicz
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 5
-
- Long-Term Effects of COVID-19 6
- Co-authors
- Katarzyna Kotfis (14 shared papers)Sylwester Drożdżal (11 shared papers)Jakub Rosik (6 shared papers)Filip Machaj (4 shared papers)Bartosz Szostak (4 shared papers)Saeid Ghavami (2 shared papers)Marek Łoś (2 shared papers)Iwona Rotter (6 shared papers)
In The Last Decade
Kacper Lechowicz
13 papers receiving 704 citations
Kacper Lechowicz's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 288
- Critical Care and Intensive Care Medicine 45
- Neurology 141
- Applied Microbiology and Biotechnology 7
- Biological Psychiatry 8
Countries citing papers authored by Kacper Lechowicz
This map shows the geographic impact of Kacper Lechowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kacper Lechowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kacper Lechowicz more than expected).
Fields of papers citing papers by Kacper Lechowicz
This network shows the impact of papers produced by Kacper Lechowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kacper Lechowicz. The network helps show where Kacper Lechowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Kacper Lechowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment Hit paper breakdown → | 2021 | 190 |
| 2 | 2020 | 133 | |
| 3 | 2020 | 133 | |
| 4 | 2021 | 81 | |
| 5 | 2020 | 47 | |
| 6 | 2021 | 31 | |
| 7 | 2018 | 27 | |
| 8 | 2020 | 23 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 14 | |
| 11 | 2022 | 8 | |
| 12 | 2019 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2023 | 0 | |
| 15 | 2025 | 0 |
About Kacper Lechowicz
Kacper Lechowicz is a scholar working on Infectious Diseases, Neurology, Critical Care and Intensive Care Medicine, Behavioral Neuroscience and Molecular Biology, having authored 15 papers that have together received 718 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Intensive Care Unit Cognitive Disorders (3 papers), Stress Responses and Cortisol (2 papers), Healthcare professionals’ stress and burnout (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Infectious Diseases (288 citations), Critical Care and Intensive Care Medicine (45 citations), Neurology (141 citations), Applied Microbiology and Biotechnology (7 citations) and Biological Psychiatry (8 citations). Kacper Lechowicz has collaborated with scholars based in Poland, Canada and Germany. Frequent co-authors include Katarzyna Kotfis, Sylwester Drożdżal, Jakub Rosik, Filip Machaj, Bartosz Szostak, Saeid Ghavami, Marek Łoś, Iwona Rotter, Shahrokh Lorzadeh and Jarosław Przybyciński. Their work appears in journals such as Drug Resistance Updates, Pharmaceuticals, Clinical Interventions in Aging, Therapeutics and Clinical Risk Management and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.